Tezepelumab Biosimilar Monoclonal Antibody (TSLP) for Research

Cat No.: GMP-Bios-ab-567

Pre-Made Tezepelumab biosimilar, Whole Mab: Anti-TSLP therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Tezepelumab (INN; development codes MEDI9929 and AMG 157) is a human monoclonal antibody designed for the treatment of asthma and atopic dermatitis. It blocks thymic stromal lymphopoietin (TSLP), an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.

Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-567-1mg 1mg 243

Size: 1mg | 10mg | 100mg



Product Details

Products Name (INN Index) Pre-Made Tezepelumab biosimilar, Whole Mab: Anti-TSLP therapeutic antibody
INN Name Tezepelumab
TargetTSLP
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Preregistration
Est. StatusActive
100% SI Structure5j13:CB
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesAmgen;AstraZeneca;Bispebjerg Hospital;Lund University;MedImmune;University of Copenhagen;University of Newcastle in Australia
Conditions Approvedna
Conditions ActiveAsthma;Atopic dermatitis;Rhinosinusitis;Chronic obstructive pulmonary disease
Conditions Discontinuedna
Development Techna



About target - TSLP

1. Protein Thymic stromal lymphopoietin

2. Gene TSLP

3. Organism Homo sapiens (Human)

Function
Isoform 2: Cytokine that induces the release of T-cell-attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c+ dendritic cells. Can induce allergic inflammation by directly activating mast cells.

Isoform 2: May act as an antimicrobial peptide in the oral cavity and on the skin. Miscellaneous
Is not capable of signal transduction by itself, but operates through the adapter protein HCST (PubMed:10426994 and PubMed:15894612). Some families of ligands for human and mouse KLRK1 receptors have been characterized being very similar in structure and highly likely to be orthologs. In humans, an additional distinct subfamily of ligands (MICA and MICB) differs structurally, having an extra MHC alpha 3-like domain (PubMed:23298206).